Baker Brothers Advisors - VERA THERAPEUTICS INC ownership

VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 52 filers reported holding VERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of VERA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,350,747
-9.1%
146,464
-56.1%
0.01%0.0%
Q1 2023$2,586,664
-59.9%
333,3330.0%0.01%
-64.1%
Q4 2022$6,449,994
-9.2%
333,3330.0%0.04%
-17.0%
Q3 2022$7,103,000
+56.6%
333,3330.0%0.05%
+80.8%
Q2 2022$4,537,000
-42.1%
333,3330.0%0.03%
-42.2%
Q1 2022$7,830,000333,3330.04%
Other shareholders
VERA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 5,450,000$74,719,5008.73%
Kynam Capital Management, LP 2,956,053$40,527,4876.63%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 758,355$10,381,8803.50%
Sofinnova Investments, Inc. 3,467,156$47,534,7093.00%
Altium Capital Management LP 333,681$4,574,7672.39%
Eversept Partners, LP 1,478,489$20,270,0841.72%
SECTORAL ASSET MANAGEMENT INC 357,139$4,896,3760.95%
Carlyle Group Inc. 1,438,155$19,688,3420.85%
Orbimed Advisors 1,518,115$20,813,3570.44%
Woodline Partners LP 2,562,600$35,133,2460.41%
View complete list of VERA THERAPEUTICS INC shareholders